CClinicalTrials.gg
Active, not recruitingNCT06265831HandfanCOPDUpdated Jun 18, 2024

The Effect of Face Hand Fan Application on Dyspnea

An interventional study of Hand-fan application to the face in COPD, sponsored by Bartın Unıversity. Active, not recruiting at 1 site in Turkey. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-18.

Sponsored by Bartın Unıversity · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Apr 2023, registered Feb 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
61
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Diagnosing and managing dyspnea in patients with COPD is very important. Although pharmacological and non-pharmacological methods are used in the management of dyspnea, it is recommended that pharmacological methods be supported by non-pharmacological methods. Hand fan application, which is one of the non-pharmacological methods used in dyspnea management, provides an increase in self-efficacy in patients in addition to the stimulation of cold air flow to the trigeminal nerve branches, mucosa and skin. Although there are studies reporting that applying cold air to the face with a hand fan is effective in reducing the severity of dyspnea in different patient groups, the number of studies examining the effectiveness of applying cold air to the face with a hand fan in patients with COPD is quite limited. This project was planned to determine the effect of applying cold air to the face with a fan on the severity of dyspnea and quality of life in COPD patients.

Read the detailed description

Chronic obstructive pulmonary disease (COPD) is a chronic disease with a high incidence both in our country and around the world. Dyspnea is one of the common problems in COPD patients. Dyspnea is an important symptom that limits patients' physical mobility, causes psychological problems such as anxiety, depression, and panic, and negatively affects their quality of life. Therefore, it is very important to diagnose and manage dyspnea in patients with COPD. Although pharmacological and non-pharmacological methods are used in the management of dyspnea, it is recommended that pharmacological methods be supported by non-pharmacological methods. Hand fan application, which is one of the non-pharmacological methods used in dyspnea management, provides an increase in self-efficacy in patients in addition to the stimulation of cold airflow to the trigeminal nerve branches, mucosa, and skin. Although there are studies reporting that applying cold air to the face with a hand fan is effective in reducing the severity of dyspnea in different patient groups, the number of studies examining the effectiveness of applying cold air to the face with a hand fan in patients with COPD is quite limited. This project was planned to determine the effect of applying cold air to the face with a fan on the severity of dyspnea and quality of life in COPD patients.

Method: The research was planned as a randomized, controlled experimental design. The population of the research consists of patients treated with a diagnosis of COPD in Bartın State Hospital Chest Diseases Service. Considering the data obtained from a similar study, the sample was calculated as 64 patients in the intervention group and 64 patients in the control group, for a total of 128 patients. Data will be collected using the Descriptive Information Form, Vital Signs Form, Modified Borg Scale, and Saint George Respiratory Questionnaire.

Data will be collected by researchers through face-to-face interviews with COPD patients treated at Bartın State Hospital Chest Diseases Service. Patients receiving treatment with a diagnosis of COPD will be randomized into intervention and control groups. In the control group, the Patient Diagnosis Form, Vital Signs Form, Modified Borg Scale, and Saint George Respiratory Questionnaire Form will be filled in at the first interview. The clinic's routine care protocol will be applied to the patients in the control group, and the researchers will fill out a vital signs form every day for 7 days, and the patients will be followed up. At the first meeting of the intervention group, the Patient Identification Form, Vital Signs Form, Modified Borg Scale, and Saint George Respiratory Questionnaire Form will be filled out. Afterward, training will be given (accompanied by an academic advisor) on how to apply cold air to the face with a hand fan (3 times a day for 5 minutes) for dyspnea management. Additionally, patients will be given a hand-fan application brochure. The researchers will monitor the patient every day for a week (7 days), fill out the vital signs form, and the final test will be administered by the researchers on the 8th day.

02

Conditions studied

  • COPD

Browse trials for

Keywords

  • dyspnea
  • COPD
  • quality of life
03

In context

Dyspnea

656 studies on the registry are indexed under Dyspnea; 153 are open to participants now.

This study's enrollment of 61 is above the median of 48 across 430 interventional studies indexed under Dyspnea.

Browse Dyspnea studies →

Lead sponsor

Bartın Unıversity is the lead sponsor of 45 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Having been diagnosed with COPD at least 6 months ago,
  • Being over 18 years of age,
  • No open wounds on the face for any reason,
  • Lung cancer, tuberculosis, asthma etc. absence of other respiratory system diseases,
  • Not having a hearing or speech impairment,
  • Not having a cognitive disability
  • Volunteering to participate in the research.

Exclusion criteria

Exclusion Criteria:

  • Being diagnosed with COPD less than 6 months ago,
  • Being under 18 years of age,
  • Having an open wound on the face for any reason,
  • Lung cancer, tuberculosis, asthma etc. Having other respiratory system diseases,
  • Having hearing and speech impairment,
  • Having a cognitive disability
  • Not volunteering to participate in the research.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
61 participants (actual)

Study arms

  • Experimental
    Hand-fan application to the face

    At the first meeting of the hand-fan application to the face group, the Patient Identification Form, Vital Signs Form, Modified Borg Scale, and Saint George Respiratory Questionnaire Form will be filled out. Afterward, training will be given (accompanied by an academic advisor) on how to apply cold air to the face with a hand fan (3 times a day for 5 minutes) for dyspnea management. Additionally, patients will be given a hand-fan application brochure. The researchers will monitor the patient every day for a week (7 days), fill out the vital signs form, and the final test will be administered by the researchers on the 8th day.

    Other: Hand-fan application to the face

  • No intervention
    Standard care group

    In the standard care group, the Patient Diagnosis Form, Vital Signs Form, Modified Borg Scale, and Saint George Respiratory Questionnaire Form will be filled in at the first interview. The clinic's routine care protocol will be applied to the patients in the control group, and the researchers will fill out a vital signs form every day for a week, and the patients will be followed up.

Interventions

  • OtherHand-fan application to the face

    Hand fan application is one of the applications recommended in managing dyspnea in evidence-based guidelines. Hand fan application effectively reduces shortness of breath by stimulating cold airflow to the 2nd and 3rd trigeminal nerve branches, mucosa, and skin.

06

What researchers measure

Primary outcomes

  1. Modified Borg Scale

    The Modified Borg Scale was first developed to measure the effort expended during physical exercise. Later, MBS was revised in 1982 and became a scale consisting of 12 items that diagnose the severity of dyspnea according to its degree. As the points on the scale increase, the severity of dyspnea increases (0: None, 0.5: Very very mild, 1: Very mild, 2: Mild, 3: Moderate, 4: Somewhat severe, 5: Severe, 6: 7: Very severe, 8: ....., 9: Very very serious, 10: Maximum). Although MBS was first used to define the severity of exertional dyspnea, it is now also used to evaluate the severity of resting dyspnea.

    Time frame: a week (seven days)

Secondary outcomes

  1. Saint George Respiratory Questionnaire

    Saint George Respiratory Questionnaire is a survey developed to evaluate the health-related quality of life of patients diagnosed with COPD. The survey consists of 50 items and 3 main sections. These sections; symptoms (8 items), activity (16 items) and effects of the disease (26 items). The questionnaire evaluates respiratory symptoms, activities restricted due to dyspnea, and the impact of this condition on daily life. In the evaluation, the total score of the survey is distributed between 0 and 100. A score of 0 indicates that there is no deterioration in the quality of life, while a score of 100 indicates that the quality of life is increasingly negatively affected. In the reliability analysis of SGSA, Cronbach's alpha coefficient was found to be 0.88 for the entire scale.

    Time frame: a week (seven days)

07

Study locations

1 site
  • Necmiye ÇÖMLEKÇİ
    Bartın, 74100, Turkey
08

References and documents

Individual participant data

Plan to share: Yes — After the research is published as an article, the data will be shared with researchers who request it. (Personal and private information of the participants is hidden.)

Supporting information: Study protocol, Sap

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06265831
Lead sponsor
Bartın Unıversity
Collaborators
The Scientific and Technological Research Council of Turkey
Responsible party
Necmiye ÇÖMLEKÇİ (Research Assistant, PhD, Bartın Unıversity) — Principal investigator
First posted
Feb 20, 2024
Start date
Apr 1, 2023
Primary completion
Nov 30, 2023
Completion
Jun 2024 (estimated)
Last update
Jun 18, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion